Literature DB >> 1717468

Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligand.

R A Orlando1, D A Cheresh.   

Abstract

Cell adhesion is characterized by an integrin-mediated ligand binding event followed by reorganization of the actin-cytoskeleton leading to cell spreading and/or migration. In this report we examine the role of integrin alpha v beta 3 in mediating cell attachment to vitronectin or a RGD-containing peptide in the presence of cytochalasin B to prevent actin polymerization. Under these conditions cell attachment to a RGD-containing peptide can be dissociated by excess soluble ligand whereas cells attached to vitronectin cannot. These results suggest that alpha v beta 3-mediated cell attachment to vitronectin results in a highly stabilized interaction that is independent of the actin-cytoskeleton. To investigate the molecular nature of this interaction alpha v beta 3 was purified to homogeneity, and its binding properties toward various ligands were measured in a solid-phase receptor assay. The data indicate that alpha v beta 3 binds to vitronectin or fibronectin in a nondissociable manner whereas a RGD-containing peptide derived from vitronectin binds specifically but is completely dissociable with a Kd of 9.4 x 10(-7) M. Moreover, chemical modification of alpha v beta 3 with limited glutaraldehyde treatment allowed vitronectin to bind in a RGD-dependent and dissociable manner, suggesting that receptor conformational changes or specific amino acid residues proximal to the ligand binding site(s) are involved in the stabilization event. Thus, in the absence of cytoskeletal proteins or other cellular components, integrin alpha v beta 3-ligand binding involves recognition of the RGD sequence leading to a highly stabilized protein-protein association.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717468

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Authors:  T Jackson; A Sharma; R A Ghazaleh; W E Blakemore; F M Ellard; D L Simmons; J W Newman; D I Stuart; A M King
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes.

Authors:  D Fischer; R P Tucker; R Chiquet-Ehrismann; J C Adams
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

3.  High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site.

Authors:  C F Barbas; L R Languino; J W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  Hypertonic enhancement of transmitter release from frog motor nerve terminals: Ca2+ independence and role of integrins.

Authors:  A H Kashani; B M Chen; A D Grinnell
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

5.  ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding.

Authors:  Ana Kasirer-Friede; Jian Kang; Bryan Kahner; Feng Ye; Mark H Ginsberg; Sanford J Shattil
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

6.  Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.

Authors:  C Cabañas; N Hogg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1.

Authors:  Jingping Zhong; Brian Eliceiri; Dwayne Stupack; Kalyani Penta; Gordon Sakamoto; Thomas Quertermous; Mike Coleman; Nancy Boudreau; Judith A Varner
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs.

Authors:  Catherine K Kuo; Joseph E Marturano; Rocky S Tuan
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-08-20

9.  Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.

Authors:  Richard H Kimura; Zhen Cheng; Sanjiv Sam Gambhir; Jennifer R Cochran
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells.

Authors:  K Nasu; T Ishida; M Setoguchi; Y Higuchi; S Akizuki; S Yamamoto
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.